Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.

Emori M, Tsukahara T, Murase M, Kano M, Murata K, Takahashi A, Kubo T, Asanuma H, Yasuda K, Kochin V, Kaya M, Nagoya S, Nishio J, Iwasaki H, Sonoda T, Hasegawa T, Torigoe T, Wada T, Yamashita T, Sato N.

PLoS One. 2013 Dec 20;8(12):e84187. doi: 10.1371/journal.pone.0084187.

2.

ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.

Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M, Saito T, Sato N.

PLoS One. 2013 Jun 6;8(6):e65158. doi: 10.1371/journal.pone.0065158.

3.

The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.

Li D, Zhang T, Gu W, Li P, Cheng X, Tong T, Wang W.

Oncol Rep. 2015 May;33(5):2291-8. doi: 10.3892/or.2015.3842.

PMID:
25760144
4.

CD109 is a potential target for triple-negative breast cancer.

Tao J, Li H, Li Q, Yang Y.

Tumour Biol. 2014 Dec;35(12):12083-90. doi: 10.1007/s13277-014-2509-5.

PMID:
25149155
5.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555.

PMID:
22608744
6.

The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.

Vogler T, Kriegl L, Horst D, Engel J, Sagebiel S, Schäffauer AJ, Kirchner T, Jung A.

Exp Mol Pathol. 2012 Feb;92(1):111-7. doi: 10.1016/j.yexmp.2011.10.010.

PMID:
22101256
7.

Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.

Hagikura M, Murakumo Y, Hasegawa M, Jijiwa M, Hagiwara S, Mii S, Hagikura S, Matsukawa Y, Yoshino Y, Hattori R, Wakai K, Nakamura S, Gotoh M, Takahashi M.

Pathol Int. 2010 Nov;60(11):735-43. doi: 10.1111/j.1440-1827.2010.02592.x.

PMID:
20946523
8.

Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.

Ueda K, Ogasawara S, Akiba J, Nakayama M, Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K, Yano H.

PLoS One. 2013 Oct 8;8(10):e75463. doi: 10.1371/journal.pone.0075463.

9.

Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.

Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, Kunisada T, Yano M, Kuji S, Hirashima Y, Arakawa A, Nishio S, Ushijima K, Ito K, Itani Y, Morishige K.

Gynecol Oncol. 2015 May;137(2):299-305. doi: 10.1016/j.ygyno.2014.12.005.

PMID:
25541259
10.

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456.

PMID:
21680574
11.

Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.

Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A.

PLoS One. 2012;7(8):e43664. doi: 10.1371/journal.pone.0043664.

12.

Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.

Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato N, Tsukamoto T.

Mod Pathol. 2013 Jan;26(1):117-24. doi: 10.1038/modpathol.2012.139.

13.

Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.

Michifuri Y, Hirohashi Y, Torigoe T, Miyazaki A, Fujino J, Tamura Y, Tsukahara T, Kanaseki T, Kobayashi J, Sasaki T, Takahashi A, Nakamori K, Yamaguchi A, Hiratsuka H, Sato N.

Biochem Biophys Res Commun. 2013 Sep 13;439(1):96-102. doi: 10.1016/j.bbrc.2013.08.021.

PMID:
23954638
14.

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.

Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ.

BMC Cancer. 2014 Oct 10;14:756. doi: 10.1186/1471-2407-14-756.

15.

Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.

Nakahata K, Uehara S, Nishikawa S, Kawatsu M, Zenitani M, Oue T, Okuyama H.

PLoS One. 2015 Apr 27;10(4):e0125454. doi: 10.1371/journal.pone.0125454.

16.

SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.

Zhang F, Lin H, Gu A, Li J, Liu L, Yu T, Cui Y, Deng W, Yan M, Li J, Yao M.

J Proteomics. 2014 May 6;102:125-36. doi: 10.1016/j.jprot.2014.03.007.

PMID:
24667143
17.

Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.

DA Cruz Paula A, Marques O, Rosa AM, DE Fátima Faria M, Rêma A, Lopes C.

Anticancer Res. 2014 Mar;34(3):1427-34.

PMID:
24596390
18.

Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.

Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K.

J Pathol. 2012 Nov;228(3):391-404. doi: 10.1002/path.4020.

PMID:
22430847
19.

Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.

Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, Tsujiuchi T.

Oncol Rep. 2010 Aug;24(2):501-5.

PMID:
20596639
20.

Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.

Bane A, Viloria-Petit A, Pinnaduwage D, Mulligan AM, O'Malley FP, Andrulis IL.

Breast Cancer Res Treat. 2013 Jul;140(1):195-205. doi: 10.1007/s10549-013-2591-1.

Items per page

Supplemental Content

Support Center